Literature DB >> 19697053

Behçet's disease: an algorithmic approach to its treatment.

Erkan Alpsoy1, Ayse Akman.   

Abstract

Behçet's disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology with the clinical features of mucocutaneous lesions, ocular, vascular, articular, gastrointestinal, urogenital, pulmonary, and neurologic involvement. Mucocutaneous lesions figure prominently in the presentation and diagnosis, and may be considered the hallmarks of BD. Therefore, their recognition may permit earlier diagnosis and treatment. Although, the treatment has become much more effective in recent years, BD is still associated with severe morbidity and considerable mortality. The main aim of the treatment should be the prevention of irreversible organ damage. Therefore, close monitoring, early and appropriate treatment is mandatory to reduce morbidity and mortality. We reviewed the current state of knowledge regarding the therapeutic approaches for BD and designed a stepwise, symptom-based, algorithmic approach, mainly based on controlled studies and our clinical experience in this field to provide a rational framework for selecting the appropriate therapy along the various treatment choices.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19697053     DOI: 10.1007/s00403-009-0990-2

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  16 in total

Review 1.  Evaluation of current therapeutic strategies in Behçet's disease.

Authors:  Iliana Alexoudi; Violetta Kapsimali; Aristides Vaiopoulos; Meletios Kanakis; George Vaiopoulos
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

2.  Peripheral arterial involvement in Behcet's disease: an analysis of the results from a Korean referral center.

Authors:  Shin-Seok Yang; Keun-Myoung Park; Yang Jin Park; Young-Wook Kim; Young Soo Do; Hong Suk Park; Kwang Bo Park; Dong-Ik Kim
Journal:  Rheumatol Int       Date:  2013-02-16       Impact factor: 2.631

3.  [Differential diagnosis of oral mucosal erosions and ulcers in children].

Authors:  S Benoit; H Hamm
Journal:  Hautarzt       Date:  2015-04       Impact factor: 0.751

Review 4.  [Immunomodulatory therapy of autoimmune diseases : Quo vadis?].

Authors:  B F Hoyer; F Hiepe
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

Review 5.  Infliximab for patients with neuro-Behcet's disease: case series and literature review.

Authors:  Afshin Borhani Haghighi; Anahid Safari; Mohammad Ali Nazarinia; Zahra Habibagahi; Saeedeh Shenavandeh
Journal:  Clin Rheumatol       Date:  2011-03-24       Impact factor: 2.980

Review 6.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

Review 7.  Pain management in neurocritical care.

Authors:  Axel Petzold; Armand Girbes
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

Review 8.  Triggering agents and microbiome as environmental factors on Behçet's syndrome.

Authors:  Gonca Mumcu; Haner Direskeneli
Journal:  Intern Emerg Med       Date:  2018-12-06       Impact factor: 3.397

9.  New Evidence-Based Treatment Approach in Behçet's Disease.

Authors:  Erkan Alpsoy
Journal:  Patholog Res Int       Date:  2011-10-05

10.  Potential Infectious Etiology of Behçet's Disease.

Authors:  Massimiliano Galeone; Roberta Colucci; Angelo Massimiliano D'Erme; Silvia Moretti; Torello Lotti
Journal:  Patholog Res Int       Date:  2011-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.